UPTIZMA Trademark

Trademark Overview


On Monday, November 25, 2019, a trademark application was filed for UPTIZMA with the United States Patent and Trademark Office. The USPTO has given the UPTIZMA trademark a serial number of 88705137. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, January 11, 2021. This trademark is owned by Galera Therapeutics, Inc.. The UPTIZMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection
uptizma

General Information


Serial Number88705137
Word MarkUPTIZMA
Filing DateMonday, November 25, 2019
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, January 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2020

Trademark Statements


Goods and ServicesPharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, January 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGalera Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Party NameGalera Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMalvern, PA 19355

Trademark Events


Event DateEvent Description
Monday, January 11, 2021ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Monday, January 11, 2021ABANDONMENT - AFTER PUBLICATION
Thursday, January 7, 2021TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, November 17, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 28, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 15, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 15, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, October 15, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, October 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 1, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 1, 2020ASSIGNED TO LIE
Thursday, August 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Tuesday, March 3, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 3, 2020NON-FINAL ACTION E-MAILED
Tuesday, March 3, 2020NON-FINAL ACTION WRITTEN
Friday, February 28, 2020ASSIGNED TO EXAMINER
Tuesday, December 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 28, 2019NEW APPLICATION ENTERED IN TRAM